Partner José Humberto Rocha and associate José María Castro
NHG advised Corporación Andina de Fomento (CAF) on the
equity investment of Patia Biopharma for the development of a
cost-efficient genetic test to identify high-risk patients of
diabetes that may contact SARS-Cov-2.
NHG advised Corporación Andina de Fomento
Back to All Thought Leadership